2022 International Congress Archives - Page 89 of 153

Malignant catatonia secondary to clozapine withdrawal: A case report

T. Thammongkolchai, P. Termsarasab (Bangkok, Thailand)
Mania induced by STN-DBS is related to the stimulation of the ventromedial subthalamic nucleus in Parkinson’s disease: a prospective study

SP. Prange, ZL. Lin, MN. Nourredine, TD. Danaila, CL. Laurencin, OLB. Lagha-Boukbiza, MA. Anheim, HK. Klinger, NL. Longato, CP. Phillipps, JV. Voirin, GP. Polo, ES. Simon, PM. Mertens, ASR. Rolland, DD. Devos, EM. Metereau, CT. Tranchant, ST. Thobois (Bron, France)
Manifestations of Parkinson’s Disease in different ethnicities in Sumatera Indonesia: A Descriptive Study

S. Marisdina, S. Handayani, Y. Diansari, A. Afriani, R. Odiesta, M. Nur'Aini (Palembang, Indonesia)
Mapping of the International Classification of Functioning, Disability and Health categories in the Pre-Assessment Information Form for People with Parkinson’s Disease.

F. Rogatto, E. Guelfi, G. Pereira, S. Silva (São Paulo, Brazil)
Mapping Side Effects in Deep Brain Stimulation – Different Approaches, Different Problems.

TA. Dembek, H. Jergas, JN. Petry-Schmelzer, C. Baldermann, J. Strelow, A. Nehls, V. Visser-Vandewalle, MT. Barbe (Cologne, Germany)
Marker Progression and Sample Sizes Estimates for Trials in Prodromal Parkinson’s Disease: A Multicenter Study

S. Joza, M. Hu, KY. Jung, D. Kunz, P. Dusek, D. Arnaldi, B. Högl, L. Ferini-Strambi, M. Terzaghi, F. Sixel-Döring, M. Puligheddu, F. Provini, S. Lewis, J. Liu, J. Bušková, A. Nicoletti, Y. Dauvilliers, C. Bassetti, M. Lawton, HJ. Kim, JS. Sunwoo, F. Bes, K. Sonka, P. Mattioli, A. Stefani, A. Ibrahim, G. Fiamingo, B. Mollenhauer, C. Trenkwalder, M. Figorilli, P. Cortelli, L. Baldelli, K. Ehgoetz Martens, Y. Li, E. Cicero, L. Guiraud, C. Schaefer, A. Pelletier, R. Postuma (Montreal, Canada)
May apomorphine be helpful for the axial symptoms of Parkinson’s Disease?

A. Alonso-Canovas, P. Perez Torre, G. Sanchez Diez, A. Patiño Paton, N. Gonzalez, I. Parees Moreno, JC. Martinez Castrillo (Madrid, Spain)
Measuring functional cognition with the Short Weekly Calendar Planning Activity in patients with Parkinson’s disease and non-manifesting LRRK2 and GBA carriers

T. Schejter Margalit, N. Ben Binyamin, A. Thaler, I. Maidan, J. Cederbaum, A. Orr-Urtreger, M. Gana Weisz, O. Goldstein, N. Giladi, A. Mirelman, R. Kizony (Tel Aviv, Israel)
Measuring what matters in Parkinson’s disease – validating real-world digital mobility outcomes for widespread adoption

A. Yarnall, C. Schlenstedt, P. Ginis, H. Hildesheim, A. Mirelman, J. Hausdorff, A. Nieuwboer, H. Gassner, L. Alcock, P. Brown, H. Hunter, I. Neatrour, L. Sutcliffe, J. Winkler, J. Klucken, J. Kudelka, M. Gordon, C. Becker, W. Maetzler, L. Rochester (Newcastle, United Kingdom)
Mechanisms and Consequences of Weight Gain After Deep Brain Stimulation of the Subthalamic Nucleus in Patients with Parkinson’s Disease

J. Steinhardt, L. Lokowandt, D. Rasche, V. Tronnier, T. Münte, S. Meyhöfer, B. Wilms, N. Brüggemann (Lübeck, Germany)